Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration.

Journal of Neurology
Daniela GalimbertiElio Scarpini

Abstract

Cerebrospinal fluid (CSF) levels of interleukin (IL)-6, IL-11 and leukaemia inhibitory factor (LIF) were evaluated in 43 patients with Alzheimer's disease (AD) and 24 patients with frontotemporal lobar degeneration (FTLD) as compared with 30 agematched controls (CON), and correlated with clinical and demographic data and with CSF biomarkers amyloid beta (A beta)42, total tau and tau phosphorylated at position 181 (P-tau). CSF IL-11 mean levels were significantly increased in AD and FTLD as compared with CON (6.5 +/- 4.6 and 6.6 +/- 5.1 versus 3.1 +/- 3.3 pg/ml, P = 0.009). IL-6 mean levels did not differ between patients and CON (P > 0.05),whereas LIF levels were not detectable in patients or in CON. In AD patients, a significantly positive correlation between MMSE scores and IL-11 CSF concentration was observed (r = 0.344, P = 0.028). No correlations with CSF A beta 42, total tau and P-tau were found. IL-11, but not IL-6 levels are increased in AD and FTLD, and the highest peaks were observed in patients with a less severe degree of cognitive deterioration, therefore suggesting a role of this cytokine in early phases of neurodegeneration.

References

Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·M J Fann, P H Patterson
Nov 1, 1993·Stem Cells·Y C Yang
Apr 1, 1996·Scandinavian Journal of Clinical and Laboratory Investigation·F Sellebjerg, M Christiansen
Jan 1, 1997·Annual Review of Immunology·T Taga, T Kishimoto
Aug 1, 1997·The International Journal of Biochemistry & Cell Biology·S X Leng, J A Elias
Jan 16, 1999·Brain Research. Molecular Brain Research·M ThierJ Weis
Apr 6, 1999·Journal of Neurovirology·M Q Xia, B T Hyman
Apr 6, 1999·Archives of Neurology·R C PetersenE Kokmen
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Apr 1, 2003·Annals of Neurology·Daniela GalimbertiUNKNOWN Dutch-Italian Alzheimer Research Group
Aug 12, 2003·Brain Research Bulletin·Elisabeth TarkowskiKaj Blennow
Jul 10, 2004·Acta Neurologica Scandinavica·K Wada-IsoeK Nakashima
Jul 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·M SjögrenE Tarkowski
Aug 18, 2004·Neurobiology of Aging·Chiara FenoglioElio Scarpini
Apr 13, 2005·Clinical Neurology and Neurosurgery·Niels Andreasen, Kaj Blennow
Jul 5, 2005·Journal of Psychiatric Research·Elke RichartzKlaus Schott
Jan 13, 2006·Archives of Neurology·William R MarkesberyDavid R Wekstein
Apr 12, 2006·Archives of Neurology·Daniela GalimbertiElio Scarpini

❮ Previous
Next ❯

Citations

Sep 18, 2009·Journal of Neurology·Kurt A Jellinger
Apr 25, 2012·Journal of Neural Transmission·Daniela Galimberti, Elio Scarpini
Mar 1, 1960·Clinica Chimica Acta; International Journal of Clinical Chemistry·J REJNEK, T BEDNARIK
Apr 21, 2012·Neurocase·Brianne Magouirk Bettcher, Joel H Kramer
Oct 15, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paramita ChakrabartyPritam Das
Apr 13, 2010·Biomarkers in Medicine·Douglas Galasko, Thomas J Montine
Aug 24, 2013·Clinical & Developmental Immunology·Elisa RidolfiDaniela Galimberti
May 2, 2013·Neurobiology of Disease·Jonathan J SabbaghJeffrey L Cummings
Feb 26, 2014·Molecular Neurobiology·Frederic BrosseronMichael T Heneka
Apr 26, 2012·Journal of Neurology·Chiara CeramiDaniela Galimberti
Sep 14, 2012·Immunopharmacology and Immunotoxicology·Gholamreza Azizi, Abbas Mirshafiey
Jul 5, 2013·The International Journal of Neuroscience·Aidonio FiolakiSotirios Giannopoulos
May 2, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Pamela Sparks SteinDolph Dawson
Jun 18, 2017·Nature Reviews. Neurology·Lieke H MeeterJohn C van Swieten
May 17, 2013·American Journal of Alzheimer's Disease and Other Dementias·Fatemeh Naddafi, Abbas Mirshafiey
Dec 15, 2017·Open Biology·Georgia R Frost, Yue-Ming Li
Nov 20, 2012·Electrophoresis·Manraj S Bhamra, Nicholas J Ashton
May 28, 2019·The International Journal of Neuropsychopharmacology·Hye Jeong LeeHyeon Soo Kim
Jan 11, 2020·Frontiers in Aging Neuroscience·Georgia R FrostYue-Ming Li
Nov 11, 2011·CNS Neuroscience & Therapeutics·Joseph Butchart, Clive Holmes
Jul 3, 2019·International Journal of Molecular Sciences·Eryn L WerryMichael Kassiou
Jul 22, 2019·Nature Reviews. Neurology·Fiona BrightJillian J Kril
Nov 18, 2011·Alzheimer Disease and Associated Disorders·Daniel A LlanoRobert A Lenz
Nov 15, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Imogen Joanna SwiftJonathan Daniel Rohrer
Dec 19, 2020·Journal of Alzheimer's Disease : JAD·Xiuzhe WangYuwu Zhao
Apr 6, 2021·Journal of Alzheimer's Disease : JAD·Gustaf BoströmMartin Ingelsson
Jan 18, 2011·Brain Research Reviews·Anneleen SpoorenSarah Gerlo
Oct 5, 2021·Journal of Neuroinflammation·Aitana Sogorb-EsteveJonathan D Rohrer
Aug 10, 2010·Biological Psychiatry·Walter SwardfagerNathan Herrmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.